Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease

Area of Science:

• Cardiology
• Infectious Diseases
• Biomarkers

Background:

• Left ventricular dysfunction is a frequent complication of Chagas' disease.
• Early detection of cardiac involvement is crucial for timely treatment and improved prognosis.
• Current diagnostic methods may not always be sufficient for identifying all affected individuals.

Purpose of the Study:

• To evaluate the utility of plasma brain natriuretic peptide (BNP) measurement in detecting left ventricular dysfunction in Chagas' disease.
• To determine the optimal BNP concentration threshold for identifying patients requiring further investigation or treatment.

Main Methods:

• The study included patients with Chagas' disease and abnormal electrocardiogram or chest radiograph findings.
• Plasma BNP concentrations were measured.
• Sensitivity, specificity, and predictive values were calculated for a specific BNP threshold.

Main Results:

• A plasma BNP concentration of 60.7 pmol/L or higher demonstrated high diagnostic accuracy.
• The threshold achieved 80% sensitivity and 97% specificity for detecting left ventricular dysfunction.
• Positive and negative predictive values were 80% and 97%, respectively.

Conclusions:

• Plasma BNP measurement is a valuable and accessible tool for screening Chagas' disease patients for left ventricular dysfunction.
• This biomarker can help identify individuals who would benefit from further cardiac assessment and management.
• BNP testing can streamline the diagnostic pathway for Chagas' disease cardiomyopathy.